The FDA sent Stryker a warning letter for quality concerns at the device maker's Portage, Mich., facility, according to Medscape Today. The FDA said Stryker had marketed devices without approval, and pointed out that the device manufacturer failed to notify the regulatory body of a product recall, according to the report. Stryker submitted a plan to correct the quality and recall issues.
More Articles on Devices:
13 Recent Device Company Executive & Leadership Changes
NLT Spine Opens US Subsidiary
Alphatec Solus Fusion Device Receives FDA 510(k) Clearance
More Articles on Devices:
13 Recent Device Company Executive & Leadership Changes
NLT Spine Opens US Subsidiary
Alphatec Solus Fusion Device Receives FDA 510(k) Clearance